Claire Mazumdar
Director; Director, Chief Executive Officer · 9 filings · Latest: Aug 10, 2026
Bicara Therapeutics Inc.
Relay Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Aug 10, 2026 | Sale | $27.98 | 10,000 | $279.8K | 362,152 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Aug 10, 2026 | Option Exercise | $3.79 | 10,000 | $37.9K | 372,152 | |
BCAX | Mazumdar Claire | — | Aug 10, 2026 | Proposed Sale | $27.83 | 10,000 | $278.3K | — | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Jul 10, 2026 | Sale | $28.42 | 10,000 | $284.2K | 362,152 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Jul 10, 2026 | Option Exercise | $3.79 | 10,000 | $37.9K | 372,152 | |
BCAX | Mazumdar Claire | — | Jul 10, 2026 | Proposed Sale | $29.68 | 10,000 | $296.8K | — | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | May 18, 2026 | Sale | $20.04 | 15,000 | $300.6K | 362,152 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | May 18, 2026 | Option Exercise | $3.79 | 15,000 | $56.8K | 377,152 | |
BCAX | Mazumdar Claire | — | May 18, 2026 | Proposed Sale | $20.92 | 15,000 | $313.8K | — | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Apr 20, 2026 | Sale | $23.61 | 15,000 | $354.1K | 362,152 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Apr 20, 2026 | Option Exercise | $3.79 | 15,000 | $56.8K | 377,152 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Apr 16, 2026 | Option Exercise | $4.54 | 22,760 | $103.4K | 362,152 | |
BCAX | Mazumdar Claire | — | Apr 20, 2026 | Proposed Sale | $23.74 | 15,000 | $356.1K | — | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Mar 20, 2026 | Sale | $18.95 | 1,596 | $30.2K | 339,392 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Mar 20, 2026 | Option Exercise | $3.79 | 1,596 | $6.0K | 340,988 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Mar 19, 2026 | Sale | $18.78 | 6,905 | $129.7K | 339,392 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Mar 19, 2026 | Option Exercise | $3.79 | 6,905 | $26.2K | 346,297 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Mar 18, 2026 | Sale | $18.84 | 6,499 | $122.4K | 339,392 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Mar 18, 2026 | Option Exercise | $3.79 | 6,499 | $24.6K | 345,891 | |
BCAX | Mazumdar Claire | — | Mar 20, 2026 | Proposed Sale | $18.95 | 1,596 | $30.2K | — |
Page 1 of 2
Next →